Similar articles for PMID: 32169915

Year	Number of Results
2004	1
2005	2
2006	1
2008	1
2010	2
2011	3
2012	3
2013	7
2014	3
2015	16
2016	11
2017	18
2018	18
2019	10
2020	2
2024	0

1

Patient Travel Concerns After Treatment with ¹⁷⁷Lu-DOTATATE.

Kendi AT, Mailman JA, Naraev BG, Mercer DJ, Underwood JK, Halfdanarson TR. Kendi AT, et al. J Nucl Med. 2020 Apr;61(4):496-497. doi: 10.2967/jnumed.120.243238. Epub 2020 Mar 13. J Nucl Med. 2020. PMID: 32169915 Free article. No abstract available.

2

Phase 3 Trial of ¹⁷⁷Lu-Dotatate for Midgut Neuroendocrine Tumors.

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.

3

NANETS/SNMMI Procedure Standard for Somatostatin Receptor-Based Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE.

Hope TA, Abbott A, Colucci K, Bushnell DL, Gardner L, Graham WS, Lindsay S, Metz DC, Pryma DA, Stabin MG, Strosberg JR. Hope TA, et al. J Nucl Med. 2019 Jul;60(7):937-943. doi: 10.2967/jnumed.118.230607. J Nucl Med. 2019. PMID: 31263080 Free article.

4

High clinical and morphologic response using ⁹⁰Y-DOTA-octreotate sequenced with ¹⁷⁷Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours.

Kong G, Callahan J, Hofman MS, Pattison DA, Akhurst T, Michael M, Eu P, Hicks RJ. Kong G, et al. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):476-489. doi: 10.1007/s00259-016-3527-x. Epub 2016 Sep 27. Eur J Nucl Med Mol Imaging. 2017. PMID: 27678267 Clinical Trial.

5

Safety and Effectiveness of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy After Regional Hepatic Embolization in Patients With Somatostatin-Expressing Neuroendocrine Tumors.

Hamiditabar M, Ali M, Bolek L, Vahdati G, Tworowska I, Delpassand ES. Hamiditabar M, et al. Clin Nucl Med. 2017 Nov;42(11):822-828. doi: 10.1097/RLU.0000000000001818. Clin Nucl Med. 2017. PMID: 28832377

6

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

Valkema R, Pauwels SA, Kvols LK, Kwekkeboom DJ, Jamar F, de Jong M, Barone R, Walrand S, Kooij PP, Bakker WH, Lasher J, Krenning EP. Valkema R, et al. J Nucl Med. 2005 Jan;46 Suppl 1:83S-91S. J Nucl Med. 2005. PMID: 15653656 Free article. Clinical Trial.

7

Long-term results and tolerability of tandem peptide receptor radionuclide therapy with ⁹⁰Y/¹⁷⁷Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study.

Kunikowska J, Pawlak D, Bąk MI, Kos-Kudła B, Mikołajczak R, Królicki L. Kunikowska J, et al. Ann Nucl Med. 2017 Jun;31(5):347-356. doi: 10.1007/s12149-017-1163-6. Epub 2017 Mar 18. Ann Nucl Med. 2017. PMID: 28316066

8

177Lu-DOTATATE PRRT in Patients with Metastatic Neuroendocrine Tumor and a Single Functioning Kidney: Tolerability and Effect on Renal Function.

Ranade R, Basu S. Ranade R, et al. J Nucl Med Technol. 2016 Jun;44(2):65-9. doi: 10.2967/jnmt.115.168146. Epub 2016 Feb 4. J Nucl Med Technol. 2016. PMID: 26848166 Free article.

9

Peptide receptor radionuclide therapy with (177)Lu labeled somatostatin analogs DOTATATE and DOTATOC: contrasting renal dosimetry in the same patient.

Kulkarni HR, Schuchardt C, Baum RP. Kulkarni HR, et al. Recent Results Cancer Res. 2013;194:551-9. doi: 10.1007/978-3-642-27994-2_32. Recent Results Cancer Res. 2013. PMID: 22918782

10

¹⁷⁷Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors.

Das S, Al-Toubah T, El-Haddad G, Strosberg J. Das S, et al. Expert Rev Gastroenterol Hepatol. 2019 Nov;13(11):1023-1031. doi: 10.1080/17474124.2019.1685381. Epub 2019 Oct 30. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31652074 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year